Danyelza (naxitamab-gqgk)

  • Brand Name: Danyelza
  • Innovator Brand Name: Danyelza
  • API: Naxitamab-gqgk
  • Dosage Form: 1 Vial (Per Box)
  • Strength: 40mg/10ml
  • Manufacturer Name: Y-mAbs Therapeutics, Inc.
Get Price

Description

Buy Danyelza (naxitamab-gqgk) Online

Danyelza (Naxitamab-gqgk) is a GD2-binding monoclonal antibody used, along with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have shown a partial response, minor response, or stable disease to prior therapy.

Dosage: The recommended dosage of naxitamab-gqgk is 3 mg/kg daily (up to 150 mg daily) on Days 1, 3, and 5 of each treatment cycle, administered as an intravenous infusion after dilution in combination with GM-CSF subcutaneously. Treatment cycles are repeated every 4 weeks until complete response or partial response, followed by 5 additional cycles every 4 weeks. Subsequent cycles may be repeated every 8 weeks. Discontinue your naxitamab-gqgk dosage and GM-CSF for disease progression or unacceptable toxicity.

Side Effects: The most commonly reported danyelza side effects (≥25%) include:

  • Pain
  • Tachycardia
  • Vomiting
  • Cough
  • Nausea
  • Diarrhea
  • Decreased appetite
  • Hypertension
  • Fatigue
  • Urticaria
  • Pyrexia
  • Headache
  • Injection site reaction
  • Edema
  • Anxiety
  • Localized edema
  • Irritability
  • Erythema multiforme
  • Peripheral neuropathy
  • Infusion-related reaction

Warnings and Precautions:

  • The danyelza uses is restricted in patients with a history of severe hypersensitivity reaction to it.
  • Monitor patients for signs/symptoms of infusion reactions during and for at least 2 hours following completion of each naxitamab-gqgk infusion.
  • Monitor patients for blood pressure during infusion, and at least daily on Days 1-8 of each cycle of danyelza injection and assess for complications of hypertension including RPLS.
  • The mechanism of action of danyelza suggest that it may cause fetal harm if administered to a pregnant woman.
  • Women should avoid breastfeeding during treatment with naxitamab-gqgk and for two months following the final dose.

More info

Storage: Store the danyelza vials refrigerated at temperature 2°C to 8°C (36°F to 46°F) in the outer carton to protect from light until time of use.

Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the DANYELZA at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the DANYELZA Injections.

Buying Procedure: In order to buy DANYELZA, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919650877511 or an Email to us at: info@theindianpharma.com along with the legitimate ID Proof, standard Prescription and Medical Reports.

Conclusions: Naxitamab therapy is specifically an anti-GD2 mAb. It demonstrated a high CR rate of 67 percent and an overall objective response rate of 75 percent in a high-risk patient population. Treatment with naxitamab offers an unique option for patients in the outpatient setting.

FAQ

What is Danyelza?
Danyelza is an anti-cancer agent, used along with granulocyte-macrophage colony-stimulating factor (GM-CSF) for people aged one year and older with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy.

What does Danyelza contain as an active substance?
The medication Danyelza specifically contains the active substance Naxitamab-gqgk.

How is Naxitamab-gqgk supplied?
Naxitamab-gqgk is supplied as Injection: 40 mg/10 mL (4 mg/mL) clear to slightly opalescent and colorless to slightly yellow solution in a single-dose vial.

How much does Danyelza Cost?
The danyelza price in India usually can vary depending on the wholesaler/pharmacy you visit. Danyelza is available as a brand name drug only, a generic version is not yet available.

What is the best price for Naxitamab-gqgk?
Please contact Toll-free: +91 1800 889 1064|+919650877511 for naxitamab price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Can I get Danyelza (Naxitamab-gqgk) even if I am not based in India?
The Indian Pharma helps patients in accessing or importing Danyelza (Naxitamab-gqgk), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.

Reviews

There are no reviews yet.

Be the first to review “Danyelza (naxitamab-gqgk)”

Your email address will not be published.

×